There are three main stages of Alzheimer’s Disease, and while the disease affects each individual in a unique way, the disease can be categorized in three major stages, Mild, Moderate, and Severe.
Mild Alzheimer’s (also known as MCI, or Mild Cognitive Impairment)
“In the early stages of Alzheimer's, a person may function independently. He or she may still drive, work and be part of social activities. Despite this, the person may feel as if he or she is having memory lapses, such as forgetting familiar words or the location of everyday objects. Friends, family or neighbors begin to notice difficulties. During a detailed medical interview, doctors may be able to detect problems in memory or concentration.”
Moderate Alzheimer’s “Moderate Alzheimer's is typically the longest stage and can last for many years. As the disease progresses, the person with Alzheimer's will require a greater level of care. You may notice the person with Alzheimer's confusing words, getting frustrated or angry, or acting in unexpected ways, such as refusing to bathe. Damage to nerve cells in the brain can make it difficult to express thoughts and perform routine tasks.”
Severe Alzheimer’s “In the final stage of this disease, individuals lose the ability to respond to their environment, to carry on a conversation and, eventually, to control movement. They may still say words or phrases, but communicating pain becomes difficult. As memory and cognitive skills continue to worsen, personality changes may take place and individuals need extensive help with daily activities.”
PMN: ProMIS Neurosciences is a development stage biotech company that discovers and develops game changing precision therapeutics for treatment of neurodegenerative diseases, in particular Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). Join their Investor Group on 8020 Connect to stay in-the-know about their technology.
Learn more about investing - take a quick tour of 8020 Connect.Show me the quick tour tag_faces